Men's Cancer

BC Cancer’s Personalized OncoGenomics (POG) Program is a world-leading initiative applying whole-genome and transcriptome analysis (WGTA) to inform real-time treatment decisions for patients with advanced, hard-to-treat cancers. Using a mixed methods approach, Dr.

The CIHR-funded Catalyst project applies a mixed methods approach to enhancing shared decision-making in context to the return of genetic test results for hereditary cancer syndromes.